Format
Sort by

Send to

Choose Destination

Search results

Items: 4

1.

A novel PET tracer for the imaging of αvβ3 and αvβ5 integrins in experimental breast cancer bone metastases.

Mühlhausen U, Komljenovic D, Bretschi M, Leotta K, Eisenhut M, Semmler W, Bäuerle T.

Contrast Media Mol Imaging. 2011 Nov-Dec;6(6):413-20. doi: 10.1002/cmmi.435.

2.

Synthesis, radiofluorination and first evaluation of [18F]fluorophenylsulfonyl- and [18F]fluorophenylsulfinyl-piperidines as serotonin 5-HT2A receptor antagonists for PET.

Mühlhausen U, Sihver W, Ermert J, Coenen HH.

Nucl Med Biol. 2010 Jul;37(5):605-14. doi: 10.1016/j.nucmedbio.2010.03.003. Epub 2010 Apr 24.

PMID:
20610165
3.

Synthesis of 131I-labeled glucose-conjugated inhibitors of O6-methylguanine-DNA methyltransferase (MGMT) and comparison with nonconjugated inhibitors as potential tools for in vivo MGMT imaging.

Mühlhausen U, Schirrmacher R, Piel M, Lecher B, Briegert M, Piee-Staffa A, Kaina B, Rösch F.

J Med Chem. 2006 Jan 12;49(1):263-72.

PMID:
16392811
4.

Inhibition of O6-methylguanine-DNA methyltransferase by glucose-conjugated inhibitors: comparison with nonconjugated inhibitors and effect on fotemustine and temozolomide-induced cell death.

Kaina B, Mühlhausen U, Piee-Staffa A, Christmann M, Garcia Boy R, Rösch F, Schirrmacher R.

J Pharmacol Exp Ther. 2004 Nov;311(2):585-93. Epub 2004 Jul 13.

PMID:
15254145

Supplemental Content

Loading ...
Support Center